| Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma) |
15 |
| Scleroderma-like skin changes induced by checkpoint inhibitor therapy |
10 |
| Endocrine mucin-producing sweat gland carcinoma: Clinicopathologic, immunohistochemical, and molecular analysis of 11 cases with emphasis on MYB immunoexpression |
9 |
| Endocrine mucin-producing sweat gland carcinoma: A study of 11 cases with molecular analysis |
8 |
| BRCA1-associated protein (BAP1)-inactivated melanocytic tumors |
8 |
| Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions |
8 |
| Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern |
7 |
| Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology |
7 |
| FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia) |
6 |
| Colliding, colonizing or combining? Four cases illustrating the unique challenges presented by melanoma arising in conjunction with basal cell carcinoma |
6 |
| A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion |
6 |
| Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy |
6 |
| Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy |
6 |
| Lichen planopilaris and frontal fibrosing alopecia cannot be differentiated by histopathology |
6 |
| The pathological spectrum and clinical correlation of pigmented purpuric dermatosis-A retrospective review of 107 cases |
6 |
| Granulomatous dermatitis associated with ipilimumab therapy (ipilimumab associated granulomatous dermatitis) |
6 |
| The role of gene fusions in melanocytic neoplasms |
6 |
| Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia |
6 |
| Disseminated trichosporonosis with atypical histologic findings in a patient with acute lymphocytic leukemia |
5 |
| Factors associated with false-negative pathologic diagnosis of calciphylaxis |
5 |
| Necrobiosis lipoidica associated with sarcoidosis |
5 |
| Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features |
5 |
| Regulatory T-cells in alopecia areata |
5 |
| Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases |
5 |
| Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis |
5 |
| Evaluation of T-lymphocyte subpopulations in actinic keratosis, in situ and invasive squamous cell carcinoma of the skin |
5 |
| Granulomatous and lichenoid dermatitis after IgG4 anti-PD-1 monoclonal antibody therapy for advanced cancer |
5 |
| Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: A multi-institutional observation |
4 |
| Tumor-stage mycosis fungoides in palmoplantar localization with large-cell transformation and partial CD30 expression shows complete response to brentuximab vedotin |
4 |
| Depletion of primary cilium in acral melanoma |
4 |
| Folliculocystic and collagen hamartoma of tuberous sclerosis: A new case in a female patient and review of literature |
4 |
| Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL CD and t(14;18) expression |
4 |
| Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component |
4 |
| A primary cutaneous vascular neoplasm with histologic features of anastomosing hemangioma |
4 |
| TNF alpha and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNF alpha antagonists |
4 |
| Pilomatrix carcinoma: 12-year experience and review of the literature |
4 |
| Pediatric cutaneous T-cell post-transplant lymphoproliferative disorder: Case report and review of the literature |
4 |
| Sarcomatoid pilomatrix carcinoma |
4 |
| Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features |
4 |
| Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor |
4 |
| Angiotropism in primary cutaneous melanoma is associated with disease progression and distant metastases: A retrospective study of 179 cases |
4 |
| Expression of connexin 43 in the human hair follicle: emphasis on the connexin 43 protein levels in the bulge and through the keratinization process |
3 |
| Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen |
3 |
| High concordance of BRAF mutational status in matched primary and metastatic melanoma |
3 |
| A case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified, with cytotoxic phenotype showing multiple ulcers on the entire body |
3 |
| Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long-term follow-up data in a series of 9 cases |
3 |
| Lymphomatoid papulosis with folliculotropism, eccrinotropism and neurotropism |
3 |
| The interstitial variant of granuloma annulare: Clinicopathologic study of 69 cases with a comparison with conventional granuloma annulare |
3 |
| Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosis |
3 |
| The expression of terminal deoxynucleotidyl transferase and paired box gene 5 in Merkel cell carcinomas and its relation to the presence of Merkel cell polyomavirus DNA |
3 |
